Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000208648

Medchemexpress LLC Ritalinic acid | 19395-41-6 | MFCD06200695 | 99.8% | 219.28 g/mol | C13H17NO2 | 250 MG
SDP

Catalog No. 5000208648
Encompass_Preferred

Ritalinic acid is the primary inactive urinary metabolite of methylphenidate, supplied as a powder for research use. It is a small organic acid (CAS 19395-41-6, C13H17NO2, MW 219.28 g/mol) provided at high purity for biochemical and pharmacological studies related to attention-deficit hyperactivity disorder and narcolepsy research.

  • High purity (99.81%) suitable for analytical and research applications.
  • Available in multiple package sizes including 250 MG powder.
  • Stable as powder: -20°C (3 years), 4°C (2 years).
  • Solvent storage stability: -80°C (6 months), -20°C (1 month).

Catalog No. 50-002-08648 Supplier Medchemexpress LLC Supplier No. 250MGHYW042214
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Ritalinic acid is the primary inactive urinary metabolite of methylphenidate, supplied as a powder for research use. It is a small organic acid (CAS 19395-41-6, C13H17NO2, MW 219.28 g/mol) provided at high purity for biochemical and pharmacological studies related to attention-deficit hyperactivity disorder and narcolepsy research.

  • High purity (99.81%) suitable for analytical and research applications.
  • Available in multiple package sizes including 250 MG powder.
  • Stable as powder: -20°C (3 years), 4°C (2 years).
  • Solvent storage stability: -80°C (6 months), -20°C (1 month).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.